This week in cardiology from heartwire

View all posts »

#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...

Mar 1, 2013 14:30 EST


For the week ending March 1, 2013 we discuss the following top cardiology news from heartwire:

 

And also, in brief:

 

Join us for a comprehensive review of this week's most important cardiology news.





« Previous Post
#181: What's going to be hot at ACC 2013; rivaroxaban STEMI study hits print as FDA delivers setback; Watchman ups quality of life vs chronic warfarin in nonvalvular AF; FDA again seeks more info on rivaroxaban in ACS
Mar 7, 2013 12:12 EST Next post »
#179: NJ cardiologist received more than $100 000 in referral kickbacks; deaths doubled with high calcium intake plus supplements; widely used diclofenac associated with increased risk of CV events; functional evaluation of CAD using angiographic images
Feb 22, 2013 10:50 EST




You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access